Cureia Labs Private Limited
About Cureia Labs Private Limited
Data last updated:
Cureia Labs Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2020PTC341422. Its GSTIN is 09AAICC7901M1Z9 (Uttar Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Sweety Aggarwal and Sanjay Kumar Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 309 Crystal Plaza Premises Coop.Soc. Ltd. 3/F Room A Link Road Andheri West, Mumbai, Maharashtra, India – 400053.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.13 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹66,590 (net margin 0.3%) and EBITDA of ₹1.99 Lakh (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 197% over three years.
Company details
Contact details
Cureia Labs Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressE – 309 Crystal Plaza Premises Coop.Soc. Ltd. 3/F Room A Link Road Andheri West, Mumbai, Maharashtra, India – 400053
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cureia Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cureia Labs is professional, scientific and technical activities. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 72 | Scientific research and development |
To see the full business activity and turnover split of Cureia Labs Private Limited, buy the company report.
Financials of Cureia Labs Private Limited
FY 2025 filings availableCureia Labs Private Limited reported revenue of ₹2.13 Cr (up 455% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 197% over three years, including 455% growth in the latest year. EBITDA rose 593% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.99 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹66,590 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cureia Labs Private Limited, buy the company report.
Board of directors of Cureia Labs Private Limited
Cureia Labs has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sweety Aggarwal Also directs: Mascom Opinion Private Limited | Director | 04 Jul 2020 | 6 Years 3 Months | Current |
| Sanjay Kumar Goyal | Director | 01 Aug 2020 | 6 Years 2 Months | Current |
| Manish Aggarwal Also directs: Ventis Pharmaceuticals Private Limited, Hygenia Biotech Private Limited, Ventis Healthcare Private Limited and 1 more | Director | 04 Jul 2020 | 6 Years 3 Months | Current |
Auditor
Cureia Labs Private Limited is audited by VINOD C KUMAR AND COMPANY for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VINOD C KUMAR AND COMPANY | FY 2022 | 023903C |
Shareholding
The shareholding of Cureia Labs Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Cureia Labs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cureia Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cureia Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Cureia Labs Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
GST
Cureia Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICC7901M1Z9 | Uttar Pradesh | Active | 24 Jul 2020 |
To see the full GST registrations and return filing status of Cureia Labs Private Limited, buy the company report.
Recent activity
Cureia Labs Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Sanjay Kumar Goyal ceased to be Additional Director on 31 Dec 2021.
Frequently asked questions
Cureia Labs is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 July 2020 (6+ years old) and is registered under CIN U51909MH2020PTC341422.
Cureia Labs has 3 current directors:
- Sweety Aggarwal - Director
- Sanjay Kumar Goyal - Director
- Manish Aggarwal - Director
The latest financial statements of Cureia Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Cureia Labs is 09AAICC7901M1Z9, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Cureia Labs is U51909MH2020PTC341422. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cureia Labs was incorporated on 04 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Sanjay Kumar Goyal ceased to be Additional Director on 31 Dec 2021. Sanjay Kumar Goyal was appointed as Director on 01 Aug 2020. Manish Aggarwal was appointed as Director on 04 Jul 2020. Cureia Labs has 4 board changes on record in total.
The registered office of Cureia Labs is at E – 309 Crystal Plaza Premises Coop.Soc. Ltd. 3F Room A Link Road Andheri West, Mumbai, Maharashtra, India – 400053.
Cureia Labs operates in the pharma industry, in the drug formulation and development segment.
Cureia Labs can be reached at its registered office: E – 309 Crystal Plaza Premises Coop.Soc. Ltd. 3F Room A Link Road Andheri West, Mumbai, Maharashtra, India – 400053.